0000091668 SOLITRON DEVICES INC false --02-28 Q1 2027 0.01 0.01 500,000 500,000 0 0 0.01 0.01 10,000,000 10,000,000 2,152,703 2,152,703 431,677 2,147,703 2,147,703 436,677 0 0 10 0 0 0 0 0 0 false false false false 00000916682026-03-012026-05-31 xbrli:shares 00000916682026-07-10 thunderdome:item iso4217:USD 00000916682026-05-31 00000916682026-02-28 iso4217:USDxbrli:shares 00000916682025-03-012025-05-31 0000091668sodi:CommonStockOutstandingMember2025-02-28 0000091668us-gaap:TreasuryStockCommonMember2025-02-28 0000091668us-gaap:AdditionalPaidInCapitalMember2025-02-28 0000091668us-gaap:RetainedEarningsMember2025-02-28 00000916682025-02-28 0000091668sodi:CommonStockOutstandingMember2025-03-012025-05-31 0000091668us-gaap:AdditionalPaidInCapitalMember2025-03-012025-05-31 0000091668us-gaap:TreasuryStockCommonMember2025-03-012025-05-31 0000091668us-gaap:RetainedEarningsMember2025-03-012025-05-31 0000091668sodi:CommonStockOutstandingMember2025-05-31 0000091668us-gaap:TreasuryStockCommonMember2025-05-31 0000091668us-gaap:AdditionalPaidInCapitalMember2025-05-31 0000091668us-gaap:RetainedEarningsMember2025-05-31 00000916682025-05-31 0000091668sodi:CommonStockOutstandingMember2026-02-28 0000091668us-gaap:TreasuryStockCommonMember2026-02-28 0000091668us-gaap:AdditionalPaidInCapitalMember2026-02-28 0000091668us-gaap:RetainedEarningsMember2026-02-28 0000091668sodi:CommonStockOutstandingMember2026-03-012026-05-31 0000091668us-gaap:TreasuryStockCommonMember2026-03-012026-05-31 0000091668us-gaap:AdditionalPaidInCapitalMember2026-03-012026-05-31 0000091668us-gaap:RetainedEarningsMember2026-03-012026-05-31 0000091668sodi:CommonStockOutstandingMember2026-05-31 0000091668us-gaap:TreasuryStockCommonMember2026-05-31 0000091668us-gaap:AdditionalPaidInCapitalMember2026-05-31 0000091668us-gaap:RetainedEarningsMember2026-05-31 0000091668sodi:NoncurrentSecuritiesMember2026-03-012026-05-31 0000091668sodi:NoncurrentSecuritiesMember2025-03-012025-05-31 0000091668us-gaap:FairValueInputsLevel1Membersodi:CommonStocksMember2026-05-31 0000091668us-gaap:FairValueInputsLevel2Membersodi:CommonStocksMember2026-05-31 0000091668us-gaap:FairValueInputsLevel3Membersodi:CommonStocksMember2026-05-31 0000091668sodi:CommonStocksMember2026-05-31 0000091668us-gaap:FairValueInputsLevel1Member2026-05-31 0000091668us-gaap:FairValueInputsLevel2Member2026-05-31 0000091668us-gaap:FairValueInputsLevel3Member2026-05-31 0000091668us-gaap:FairValueInputsLevel1Membersodi:CommonStocksMember2026-02-28 0000091668us-gaap:FairValueInputsLevel2Membersodi:CommonStocksMember2026-02-28 0000091668us-gaap:FairValueInputsLevel3Membersodi:CommonStocksMember2026-02-28 0000091668sodi:CommonStocksMember2026-02-28 0000091668us-gaap:FairValueInputsLevel1Member2026-02-28 0000091668us-gaap:FairValueInputsLevel2Member2026-02-28 0000091668us-gaap:FairValueInputsLevel3Member2026-02-28 xbrli:pure 00000916682026-05-312026-05-31 00000916682026-02-282026-02-28 0000091668sodi:AcquisitionOfMicroEngineeringIncMember2026-02-28 0000091668sodi:AcquisitionOfMicroEngineeringIncMember2025-02-28 0000091668sodi:AcquisitionOfMicroEngineeringIncMember2026-03-012026-05-31 0000091668sodi:AcquisitionOfMicroEngineeringIncMember2025-03-012026-02-28 0000091668sodi:AcquisitionOfMicroEngineeringIncMember2026-05-31 utr:Y 0000091668us-gaap:BuildingMember2026-05-31 0000091668us-gaap:BuildingImprovementsMember2026-05-31 0000091668us-gaap:LeaseholdImprovementsMembersrt:MaximumMember2026-05-31 0000091668us-gaap:MachineryAndEquipmentMember2026-05-31 0000091668us-gaap:ComputerEquipmentMember2026-05-31 0000091668us-gaap:VehiclesMember2026-05-31 0000091668us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembersodi:L3harrisMember2026-03-012026-05-31 0000091668us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembersodi:ConmedLinvatecMember2026-03-012026-05-31 0000091668us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembersodi:RtxCorporationMember2026-03-012026-05-31 0000091668us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembersodi:ConmedLinvatecMember2025-03-012026-02-28 0000091668us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembersodi:L3harrisMember2025-03-012026-02-28 0000091668us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembersodi:RtxCorporationMember2025-03-012026-02-28 0000091668us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembersodi:IntracomDefenseElectronicsMember2025-03-012026-02-28 0000091668sodi:DieFromESComponentsMember2026-03-012026-05-31 0000091668sodi:UsedEquipmentPurchasedFromEsComponentsMember2026-03-012026-05-31 0000091668sodi:DieFromESComponentsMember2025-03-012025-05-31 0000091668sodi:UsedEquipmentPurchasedFromEsComponentsMember2025-03-012025-05-31 0000091668sodi:ESComponentsMember2026-03-012026-05-31 0000091668sodi:ESComponentsMember2025-03-012025-05-31 0000091668srt:ChiefOperatingOfficerMember2026-03-012026-05-31 00000916682025-03-012026-02-28 0000091668sodi:OneDistributorMember2026-05-31 0000091668sodi:OneDistributorMember2026-02-28 0000091668us-gaap:PublicUtilitiesInventoryRawMaterialsMember2026-05-31 0000091668sodi:WorkinprocessMember2026-05-31 0000091668sodi:FinishedGoodsMember2026-05-31 0000091668us-gaap:PublicUtilitiesInventoryRawMaterialsMember2026-02-28 0000091668sodi:WorkinprocessMember2026-02-28 0000091668sodi:FinishedGoodsMember2026-02-28 0000091668sodi:WaferBankInventoryMember2026-05-31 0000091668sodi:WaferBankInventoryMember2026-02-28 0000091668sodi:EuropeAndAustraliaMember2026-03-012026-05-31 0000091668sodi:EuropeAndAustraliaMember2025-03-012025-05-31 0000091668sodi:CanadaAndLatinAmericaMember2026-03-012026-05-31 0000091668sodi:CanadaAndLatinAmericaMember2025-03-012025-05-31 0000091668sodi:FarEastAndMiddleEastMember2026-03-012026-05-31 0000091668sodi:FarEastAndMiddleEastMember2025-03-012025-05-31 0000091668country:US2026-03-012026-05-31 0000091668country:US2025-03-012025-05-31 0000091668us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembersodi:CustomersWithGovernmentContractsMember2026-03-012026-05-31 0000091668us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembersodi:CustomersWithGovernmentContractsMember2025-03-012025-05-31 0000091668us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembersodi:NonmilitaryScientificIndustrialCustomersAndDistributorsMember2026-03-012026-05-31 0000091668us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembersodi:NonmilitaryScientificIndustrialCustomersAndDistributorsMember2025-03-012025-05-31 0000091668us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembersodi:RtxRaytheonMember2026-03-012026-05-31 0000091668us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembersodi:RtxRaytheonMember2025-03-012025-05-31 0000091668us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembersodi:ConmedLinvatecMember2026-03-012026-05-31 0000091668us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembersodi:ConmedLinvatecMember2025-03-012025-05-31 0000091668us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembersodi:L3harrisMember2026-03-012026-05-31 0000091668us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembersodi:MoogMember2025-03-012025-05-31 0000091668us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembersodi:MajorCustomers2026Member2026-03-012026-05-31 0000091668us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembersodi:MajorCustomers2025Member2025-03-012025-05-31 0000091668us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMember2026-03-012026-05-31 0000091668us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMembersodi:FourSuppliersMember2026-03-012026-05-31 0000091668us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMembersodi:SupplierOneMember2026-03-012026-05-31 0000091668us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMembersodi:SupplierTwoMember2026-03-012026-05-31 0000091668us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMembersodi:SupplierThreeMember2026-03-012026-05-31 0000091668us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMembersodi:SupplierFourMember2026-03-012026-05-31 0000091668us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMember2025-03-012025-05-31 0000091668us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMembersodi:TwoSuppliersMember2025-03-012025-05-31 0000091668us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMembersodi:SupplierOneMember2025-03-012025-05-31 0000091668us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMembersodi:SupplierTwoMember2025-03-012025-05-31 0000091668sodi:PropertyInWestPalmBeachFloridaMember2021-04-162021-04-16 0000091668sodi:BankOfAmericaLoanOneMemberus-gaap:NotesPayableToBanksMember2021-03-01 0000091668sodi:BankOfAmericaLoanOneMemberus-gaap:NotesPayableToBanksMember2021-03-012021-03-01 0000091668sodi:BankOfAmericaLoanOneMemberus-gaap:NotesPayableToBanksMember2026-05-31 0000091668sodi:MicroPropertyMember2024-05-212024-05-21 0000091668sodi:UseableOfficeAndProductionSpaceInOrangeCountyFloridaMember2024-05-212024-05-21 0000091668sodi:BankOfAmericaLoanTwoMemberus-gaap:NotesPayableToBanksMember2024-05-21 0000091668sodi:BankOfAmericaLoanTwoMemberus-gaap:NotesPayableToBanksMember2024-05-212024-05-21 0000091668sodi:BankOfAmericaLoanTwoMemberus-gaap:NotesPayableToBanksMember2026-05-31 00000916682024-10-14 0000091668sodi:NinetyDaysAfterAgreementDateMembersrt:ChiefOperatingOfficerMember2025-08-13 0000091668sodi:NinetyDaysAfterAgreementDateMembersrt:ChiefOperatingOfficerMember2025-08-132025-08-13 0000091668sodi:Within30DaysAfterTheEndOfEachFiscalQuarterMembersrt:ChiefOperatingOfficerMember2025-08-13
 

 

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended May 31, 2026

 

or

    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____ to _____

 

Commission File No. 001-04978

 

SOLITRON DEVICES, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware22-1684144
(State or Other Jurisdiction of(I.R.S. Employer
Incorporation or Organization)Identification No.)

 

901 Sansburys Way, West Palm Beach, Florida 33411

(Address of Principal Executive Offices) (Zip Code)

 

(561) 848‑4311

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒    No  ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒    No  ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one)

 

Large accelerated filer  ☐Accelerated filer  ☐
  
Non-accelerated filer   ☒Smaller reporting company  
  
Emerging growth company   

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  No ☒ 

 

The number of shares of the registrant’s common stock, $0.01 par value, outstanding as of July 10, 2026, was 2,152,703.

 

 

    

 

SOLITRON DEVICES, INC.

 

TABLE OF CONTENTS

 

 

PART 1 - FINANCIAL INFORMATION

 

     

Page No.

Item 1.

 

Financial Statements

2
       
   

Consolidated Condensed Balance Sheets May 31, 2026 (unaudited) and February 28, 2026

2

       
   

Consolidated Condensed Statements of Operations (unaudited) Three Months Ended May 31, 2026 and 2025

3

       
   

Consolidated Condensed Statements of Changes in Stockholders’ Equity (unaudited) Three Months Ended May 31, 2026 and 2025

4

       
   

Consolidated Condensed Statements of Cash Flows (unaudited) Three Months Ended May 31, 2026 and 2025

5

       
   

Notes to Consolidated Condensed Financial Statements (unaudited)

6

       

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

15
       

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

18

       

Item 4.

 

Controls and Procedures

18

       

PART II  OTHER INFORMATION

 
       

Item 1.

 

Legal Proceedings

19

       

Item 1A

 

Risk Factors

19

       
Item 2   Unregistered Sales of Equity Securities and Use of Proceeds 19
       

Item 6.

 

Exhibits

19

       

Signatures

 

20

 

 

1

 

 

PART I FINANCIAL INFORMATION

 

ITEM 1.  FINANCIAL STATEMENTS

 

SOLITRON DEVICES, INC.

CONSOLIDATED CONDENSED BALANCE SHEETS

AS OF May 31, 2026 AND February 28, 2026

(in thousands, except for share and per share amounts)

 

  

May 31, 2026

  

February 28, 2026

 
  

unaudited

     

ASSETS

        

CURRENT ASSETS

        

Cash and cash equivalents

 $6,036  $3,914 

Marketable securities

  -   2 

Accounts receivable

  3,001   3,367 

Inventories, net

  4,567   4,132 

Prepaid expenses and other current assets

  323   142 

TOTAL CURRENT ASSETS

  13,927   11,557 
         

Property, plant and equipment, net

  8,343   8,383 

Intangible assets

  2,643   2,695 

Deferred tax asset

  975   1,332 

Long-term investment

  1,650   1,650 

Other assets

  39   323 

TOTAL ASSETS

 $27,577  $25,940 
         

LIABILITIES AND STOCKHOLDERS’ EQUITY

        

CURRENT LIABILITIES

        

Accounts payable

 $602  $470 

Customer deposits

  77   64 

Accrued contingent consideration, current

  1,119   771 

Mortgage loans, current portion

  161   160 

Accrued expenses and other current liabilities

  1,156   1,067 

TOTAL CURRENT LIABILITIES

  3,115   2,532 
         

Mortgage loans, net of current portion

  3,562   3,605 

TOTAL LIABILITIES

  6,677   6,137 
         

STOCKHOLDERS’ EQUITY

        

Preferred stock, $.01 par value, authorized 500,000 shares, none issued

  -   - 

Common stock, $.01 par value, authorized 10,000,000 shares, 2,152,703 shares outstanding, net of 431,677 treasury shares at May 31, 2026 and 2,147,703 shares outstanding, net of 436,677 treasury shares at February 28, 2026, respectively

  22   21 

Additional paid-in capital

  1,987   1,987 

Retained Earnings

  19,237   18,247 

Less treasury stock

  (346)  (452)

TOTAL STOCKHOLDERS’ EQUITY

  20,900   19,803 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

 $27,577  $25,940 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

2

 

 

SOLITRON DEVICES, INC.

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS

FOR THE three months ended May 31, 2026 AND May 31, 2025

(in thousands except for share and per share amounts)

 

  

For The Three Months ended

  

For The Three Months ended

 
  

May 31, 2026

  

May 31, 2025

 
  

unaudited

  

unaudited

 

Net sales

 $5,436  $2,700 

Cost of sales

  2,971   2,310 
         

Gross profit

  2,465   390 
         

Selling, general and administrative expenses

  930   768 
         

Operating income (loss)

  1,535   (378)
         

Other income (loss)

        

Interest income

  82   - 

Interest expense

  (62)  (74)

Dividend income

  25   41 

Realized gain on investments

  -   81 

Unrealized gain (loss) on investments

  (2)  (127)

Contingent consideration expense

  (331)  - 

Scrap income

  100   - 

Total other (loss)

  (188)  (79)
         

Net income (loss) before income taxes

 $1,347  $(457)

Income (taxes) benefit

  (357)  121 

Net income (loss)

 $990  $(336)
         

Net income (loss) per common share - basic and diluted

 $0.46  $(0.16)
         

Weighted average shares outstanding - basic and diluted

  2,152,051   2,082,553 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

3

 

 

SOLITRON DEVICES, INC.

STATEMENTS OF CHANGES IN CONDENSED CONSOLIDATED STOCKHOLDERS EQUITY

FOR THE three months ended May 31, 2026 AND May 31, 2025

(Unaudited, in thousands, except for number of shares)

 

   

Common Stock

   

Additional

   

Treasury

                 
   

Number

   

Treasury

           

Paid-in

   

Stock

   

Retained

         
   

of Shares

   

Shares

   

Amount

   

Capital

   

Amount

   

Earnings

   

Total

 
                                                         

Balance, March 1, 2025

    2,570,380       (487,827 )   $ 21     $ 1,834     $ (1,412 )   $ 17,440     $ 17,883  

Net (loss)

    -       -       -       -       -       (336 )     (336 )

Balance, May 31, 2025

    2,570,380       (487,827 )   $ 21     $ 1,834     $ (1,412 )   $ 17,104     $ 17,547  
                                                         

Balance, March 1, 2026

    2,584,354       (436,677 )   $ 21     $ 1,987     $ (452 )   $ 18,247     $ 19,803  

Adjustment of shares

    26                                             -  

Issuance/sale of shares

          5,000     $ 1             106             107  

Net income

    -       -       -       -       -       990       990  

Balance, May 31, 2026

    2,584,380       (431,677 )   $ 22     $ 1,987     $ (346 )   $ 19,237     $ 20,900  

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

4

 

 

SOLITRON DEVICES, INC.

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

FOR THE three months ended May 31, 2026 AND May 31, 2025

(unaudited, in thousands)

 

   

Three Months

   

Three Months

 
   

ended

   

ended

 
   

May 31, 2026

   

May 31, 2025

 
                 

Net income (loss)

  $ 990     $ (336 )

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

               

Depreciation

    154       141  

Amortization of intangibles

    52       53  

Net realized and unrealized (gains) losses on investments

    2       46  

Accrued interest expense on contingent consideration

    17       28  

Change in net deferred taxes

    357       (121 )

Changes in Operating Assets and Liabilities:

               

Accounts receivable

    366       379  

Inventories

    (435 )     (151 )

Prepaid expenses and other current assets

    (181 )     (80 )

Other assets, non-current

    284       127  

Contingency adjustment

    331       -  

Accounts payable

    132       293  

Customer deposits

    13       1  

Accrued expenses, other current and non-current liabilities

    89       11  

Net cash provided by operating activities

    2,171       391  
                 

Investing activities

               

Proceeds from sale of marketable securities

    -       296  

Purchases of marketable securities

    -       (82 )

Purchases of long-term investments

    -       (1,650 )

Payment of contingent consideration

    -       (409 )

Purchases of property and equipment

    (114 )     (38 )

Net cash (used in) investing activities

    (114 )     (1,883 )
                 

Financing activities

               

Proceeds from sale of stock

    107       -  

Principal payments on mortgage loan

    (42 )     (37 )

Net cash provided by (used in) financing activities

    65       (37 )
                 

Net increase (decrease) in cash and cash equivalents

    2,122       (1,529 )

Cash and cash equivalents - beginning of the year

    3,914       4,099  

Cash and cash equivalents - end of period

  $ 6,036     $ 2,570  
                 

Non-cash transactions

               
                 

Supplemental disclosures of cash flow data

               

Income taxes paid

  $ -     $ -  

Interest expense paid

  $ 44     $ 45  

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

5

 

SOLITRON DEVICES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

 

 

1.

THE COMPANY AND OPERATIONS

 

Solitron Devices, Inc., a Delaware corporation (the “Company” or “Solitron”), designs, develops, manufactures, and markets solid-state semiconductor components and related devices primarily for the military and aerospace markets. The Company was incorporated under the laws of the State of New York in 1959 and reincorporated under the laws of the State of Delaware in August 1987. In September 2023, Solitron acquired Micro Engineering Inc. (“MEI”). Since 1980, MEI has specialized in solving design layout and manufacturing challenges for electronic components. MEI specializes in low to mid volume projects that require engineering, quality systems and efficient manufacturing.

 

 

2.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

The unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.

 

The unaudited financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods. The results of operations for the three months ended May 31, 2026 are not necessarily indicative of the results to be expected for the year ending February 28, 2027.

 

The information included in this Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended February 28, 2026.

 

Use of Estimates

The consolidated condensed financial statements are prepared in accordance with U.S. GAAP. Preparation of these consolidated condensed financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable. The Company could have reasonably used different accounting estimates. This applies in particular to inventory and valuation allowance for deferred tax assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, the Company’s future financial statement presentation, financial condition, results of operations and cash flows will be affected.

 

Cash and Cash Equivalents

Cash and cash equivalents include demand deposits and money market accounts. The Company considers any short-term, highly liquid investments with maturities of three months or less as cash and cash equivalents.

 

Investments in Marketable Securities

Investments in Securities includes investments in equity securities. Investments in securities are reported at fair value with changes in unrecognized gains or losses included in other income on the condensed consolidated statements of operations.

 

6

 

The following table summarizes the Company’s marketable securities:

 

May 31, 2026

     

Gross

  

Gross

     
      

Unrealized

  

Unrealized

     

Marketable Securities:

 

Cost

  

Gains

  

Losses

  

Fair Value

 

Common Stocks

 $81,000  $-  $(81,000) $- 

 

 

February 28, 2026

     

Gross

  

Gross

     
      

Unrealized

  

Unrealized

     

Marketable Securities:

 

Cost

  

Gains

  

Losses

  

Fair Value

 

Common Stocks

 $81,000  $-  $(79,000) $2,000 

 

 

At May 31, 2026, the deferred tax asset related to unrecognized gains and losses on short-term investments was approximately 21,000, compared to a deferred tax asset of approximately $19,000 as of February 28, 2026.

 

Investment in Non-Current Securities (Long-Term Investment)

Investment in Non-Current Securities consist of investments in equity securities, which are without a readily determinable fair value, and are expected to be held for longer than one year.  As there is no readily determinable fair value, the Company has elected to use the measurement alternative methodology. Using this approach, investments in non-current equity securities are initially valued at cost. Fair value adjustments are made based on observable price changes for identical or similar investments of the same issuer as of the date the observable transaction took place (measurement date).  Qualitative assessments are completed each reporting period to determine if the fair value of the investment is less than the carrying value, and an adjustment to the carrying value will be recorded if the investment is impaired.  Changes in fair value or impairments (unrecognized gains or losses) are included in other income on the condensed consolidated statements of operations. As of the three months ended May 31, 2026 and 2025, Company received $57,000 and $0 in interest income from the investment, respectively. 

 

The following table summarizes the Company’s non-current securities, which consists of membership interest in an investment fund:

 

 

 

May 31, 2026

     

Gross

  

Gross

         
      

Unrealized

  

Unrealized

         

Non-current Securities:

 

Cost

  

Gains

  

Losses

  

Impairment

  

Fair Value

 

Long-term Investments

 $1,650,000  $-  $-  $-  $1,650,000 
                     

 

 

February 28, 2026

     

Gross

  

Gross

         
      

Unrealized

  

Unrealized

         

Non-current Securities:

 

Cost

  

Gains

  

Losses

  

Impairment

  

Fair Value

 

Long-term Investments

 $1,650,000  $-  $-  $-  $1,650,000 
 
                    

 

 

Fair Value of Financial Instruments

Accounting Standards Codification (“ASC”) Topic 820, “Fair Value Measurements and Disclosures”, defines “fair value” as the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.  ASC 820 also sets forth a valuation hierarchy of the inputs (assumptions that market participants would use in pricing an asset or liability) used to measure fair value.  This hierarchy prioritizes the inputs into the following three levels:

 

Level 1:

Observable inputs that reflect unadjusted quoted prices for identical assets or liabilities traded in active markets.

Level 2:

Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3:

Inputs that are generally unobservable. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

 

The table below shows the Company’s marketable securities, long-term investment and contingent consideration as of May 31, 2026 and February 28, 2026:

 

May 31, 2026

 

Level 1

  

Level 2

  

Level 3

  

Total

 

Common Stocks

 $-  $-  $-  $- 

Long-term Investment

  -   -   1,650,000   1,650,000 

Contingent Consideration

  -   -   1,119,000   1,119,000 
  $-  $-  $2,769,000  $2,769,000 

 

February 28, 2026

 

Level 1

  

Level 2

  

Level 3

  

Total

 

Common Stocks

 $2,000  $-  $-  $2,000 

Long-term Investment

  -   -   1,650,000   1,650,000 

Contingent Consideration

  -   -   771,000   771,000 
  $2,000  $-  $2,421,000  $2,423,000 

 

The table below shows the Company's fair value rollforward of the contingent consideration recorded as a liability for the MEI acquisition completed during the fiscal year ended February 29, 2024. Under the Purchase Agreement the Company agreed to the following potential earn-out payments as additional consideration for the Acquisition: for each of (1) the period beginning on the Closing Date of August 31, 2023, and ending on December 31, 2023, (2) the calendar year ending on December 31, 2024, (3) the calendar year ending December 31, 2025, and (3) the period beginning on January 1, 2026 and ending on the third anniversary of the Closing Date, the Company agreed to pay the MEI Shareholders 7.5% of the gross revenue actually received and collected by the Company during the applicable period from MEI’s existing customers as of the Closing and related to sales by the Company of Company products that were in existence as of the Closing. Adjustments to the contingent consideration liability were made as May 31, 2026, and February 28, 2026, for $331,000 and $346,000, respectively, due to increases in MEI's backlog.  MEI's backlog increased due to a large order received after the end of the quarter.

 

  

May 31, 2026

  

February 28, 2026

 

Contingent consideration

 $771,000  $1,233,000 

Accrued interest expense

  17,000   87,000 

Contingent consideration adjustment

  331,000   346,000 

Earn out payment

  -   (895,000)

Ending Balance

 $1,119,000  $771,000 

 

The carrying amounts of the Company’s short-term financial instruments, including accounts receivable, accounts payable, accrued expenses and other liabilities approximate their fair value due to the relatively short period to maturity for these instruments. The carrying value of long-term debt approximates fair value since the related rates of interest approximate current market rates.

 

Accounts Receivable

Accounts receivable are stated at amounts management expects to collect from outstanding balances and do not bear interest. The Company regularly monitors and assesses its risk of not collecting amounts owed by customers. At each balance sheet date, the Company recognizes an expected allowance for credit losses. In addition, at each reporting date, this estimate is updated to reflect any changes in credit risk since the receivable was initially recorded. This estimate is calculated on a pooled basis where similar risk characteristics exist. If applicable, accounts receivable are evaluated individually when they do not share similar risk characteristics which could exist in circumstances where amounts are considered at risk or uncollectible. The accounts receivable balance as of May 31, 2026, and February 28, 2026, was $3,001,000 and $3,367,000, respectively.

 

The allowance estimate is derived from a review of the Company’s historical losses based on the aging of receivables. This estimate is adjusted for management’s assessment of current conditions, reasonable and supportable forecasts regarding future events, and any other factors deemed relevant by the Company. The Company believes historical loss information is a reasonable starting point in which to calculate the expected allowance for credit losses as the Company’s portfolio segment has remained consistent since the Company’s inception. The allowance for credit losses was $0 as of May 31, 2026, and February 28, 2026.

 

The Company writes off receivables when there is information that indicates the debtor is facing significant financial difficulty and there is no possibility of recovery. If any recoveries are made from any accounts previously written off, they will be recognized in income (or an offset to credit loss expense) in the year of recovery, in accordance with the Company’s accounting policy election. The total amount of write-offs for the three months ended May 31, 2026, and  May 31, 2025 was $0.

 

7

 

Shipping and Handling

Shipping and handling costs billed to customers are recorded in net sales. Shipping costs incurred by the Company are recorded in cost of sales.

 

Inventories

Inventories are stated at the lower of cost and net realizable value. Cost is determined using the “first-in, first-out” (FIFO) method. The Company buys raw material only to fill customer orders. Excess raw material is created only when a vendor imposes a minimum quantity buy in excess of actual requirements. Such excess material will usually be utilized to meet the requirements of the customer’s subsequent orders. If excess material is not utilized after two fiscal years it is fully reserved. Any inventory item once designated as reserved is carried at zero value in all subsequent valuation activities.

 

The Company does not classify a portion of inventories as non-current since we cannot reasonably estimate based on the length of our operating cycle which items will or will not be used within twelve months.

 

The Company’s inventory valuation policy is as follows:

 

Raw material /Work in process:All material acquired or processed in the last two fiscal years is valued at the lower of its acquisition cost or net realizable value, except for wafers which function under a three- year policy. All material not used after two fiscal years is fully reserved for except wafers which were reserved for after three years. All raw wafers were fully reserved for when the wafer fab was decommissioned. Finished wafers produced in our former wafer fab are stored in the wafer bank and are considered work-in-process. Raw material in excess of five years’ usage that cannot be restocked, and slow-moving work in process are reserved for.
  
Finished goods:All finished goods with firm orders for later delivery are valued at the lower of cost or net realizable value. All finished goods with no orders are fully reserved.
  
Direct labor costs:Direct labor costs are allocated to finished goods and work in process inventory based on engineering estimates of the number of man-hours required from the different direct labor departments to bring each device to its particular level of completion.

 

Property, Plant, Equipment, and Leasehold Improvements

Property, plant, and equipment is recorded at cost. Major renewals and improvements are capitalized, while maintenance and repairs that do not extend their expected life are expensed as incurred. Depreciation is provided on a straight-line basis over the estimated useful lives of the related assets. Leasehold improvements are amortized over the shorter of the lease term or the lives of the related assets:

 

Building (years)

  39 

Building Improvements (years)

  15 

Leasehold Improvements

 

Shorter of 10 years or life of lease

 

Machinery and Equipment (years)

  5 

Computer equipment (years)

  3 

Motor vehicles (years)

  5 

 

Concentrations of Credit Risk

Financial instruments, which potentially subject the Company to concentration of credit risk, consist principally of cash and account receivables. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The Company has not experienced any losses in such accounts and believes that it is not exposed to any significant credit risk on the accounts. As of May 31, 2026, all non-interest bearing checking accounts were FDIC insured to a limit of $250,000. Deposits in excess of FDIC insured limits were approximately $620,000 at May 31, 2026, as compared to $981,000 at February 28, 2026. With respect to the account receivables, most of the Company’s products are custom made pursuant to contracts with customers whose end-products are sold to the United States Government. The Company performs ongoing credit evaluations of its customers’ financial condition and maintains allowances for potential credit losses. Actual losses and allowances have historically been within management’s expectations. As of May 31, 2026, customers with account receivables balances of 10% or greater consisted of the following: L3 Harris Technologies 35%, ConMed Linvatec 34% and RTX Corporation 12%. No other customer accounted for 10% or more of accounts receivable.  As of the fiscal year ended February 28, 2026, customers with account receivables balances of 10% or greater consisted of the following: ConMed Linvatec 26%, L3 Harris Technologies 26%, RTX Corporation 16% and Intracom Defense Electronics 12%. No other customer accounted for 10% or more of accounts receivable.

 

8

 

Net Income (Loss) Per Common Share

Net income (loss) per common share is presented in accordance with ASC 260-10 “Earnings per Share.” Basic earnings per common share are computed using the weighted average number of common shares outstanding during the period. Diluted earnings per common share incorporate the incremental shares issuable upon the assumed exercise of stock options to the extent they are not anti-dilutive using the treasury stock method. The Company had no potentially dilutive securities outstanding during the three months ended May 31, 2026 and May 31, 2025, respectively. 

 

Revenue Recognition

The Company records revenue in accordance with ASC Topic 606, “Revenue from Contracts with Customers,” which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods and services to customers. Revenue is recognized at a point in time, generally upon shipment of products to customers.

 

The core principle of the guidance in Topic 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.

 

To achieve that core principle, the Company applied the following steps:

 

1. Identify the contract(s) with a customer.

 

The Company designs, develops, manufactures and markets solid-state semiconductor components and related devices. The Company’s products are used as components primarily in the military and aerospace markets.

 

The Company’s revenues are from purchase orders and/or contracts with customers associated with manufacture of products. We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.

 

2. Identify the performance obligations in the contract.

 

The majority of the Company’s purchase orders or contracts with customers contain a single performance obligation, the shipment of products.

 

3. Determine the transaction price.

 

The transaction price reflects the Company’s expectations about the consideration it will be entitled to receive from the customer at a fixed price per unit shipped based on the terms of the contract or purchase order with the customer. To the extent our actual costs vary from the fixed price that was negotiated, we will generate more or less profit or could incur a loss.

 

4. Allocate the transaction price to the performance obligations in the contract.

 

5. Recognize revenue when (or as) the Company satisfies a performance obligation.

 

This performance obligation is satisfied when control of the product is transferred to the customer, which generally occurs upon shipment. The Company receives purchase orders for products to be delivered over multiple dates that may extend across reporting periods. The Company’s accounting policy treats shipping and handling activities as a fulfillment cost. The Company invoices for each delivery upon shipment and recognizes revenues at the fixed price for each distinct product delivered when transfer of control has occurred, which is generally upon shipment.

 

In addition, the Company may have a contract or purchase order to provide a non-recurring engineering service to a customer. These contracts are reviewed, performance obligations are determined, and we recognize revenue at the point in time in which each performance obligation is fully satisfied.

 

We recognize revenue on sales to distributors when the distributor takes control of the products ("sold-to" model).  We have agreements with distributors that allow distributors a limited credit for unsaleable products, which we refer to as a "scrap allowance." Consistent with industry practice, we also have a "stock, ship and debit" program whereby we consider requests by distributors for credits on previously purchased products that remain in distributors' inventory, to enable the distributors to offer more competitive pricing.  We have contractual arrangements whereby we provide distributors with protection against price reductions initiated by us after product is sold by us to the distributor and prior to resale by the distributor. In addition, we have a termination clause in one of our distributor agreements that would allow for a full credit for all inventory upon 60 days’ notice of terminating the agreement.

 

We recognize the estimated variable consideration to be received as revenue and record a related accrued expense for the consideration not expected to be received, based upon an estimate of product returns, scrap allowances, "stock, ship and debit" credits, and price protection credits that will be attributable to sales recorded through the end of the period.  We make these estimates based upon sales levels to our customers during the period, inventory levels at the distributors, current and projected market conditions, and historical experience under the programs. Our estimates require the exercise of significant judgments.  We believe that we have a reasonable basis to estimate future credits under the programs.

 

9

 

Related Party Transactions

The Company currently purchases and has purchased in the past die and wafers, as specified by the Company's customers, from ES Components. Mr. Aubrey, a director of the Company is a minority owner, and an immediate family member of the majority owner of ES Components. For the three months ended May 31, 2026, the Company purchased $4,000 of wafers, $0 of die and $0 of used equipment from ES Components. For the three months ended May 31, 2025, the Company purchased $50,000 of wafers, $0 of die and $0 of used equipment from ES Components. The Company has included the expenses related to die in cost of goods sold in the accompanying condensed consolidated statements of operations. The Company occasionally makes sales to ES Components. For the three months ended May 31, 2026 and May 31, 2025, sales were $0.

 

Stock based Compensation

The Company records stock-based compensation in accordance with the provisions of ASC Topic 718, "Compensation-Stock Compensation," which establishes accounting standards for transactions in which an entity exchanges its equity instruments for goods or services. Under ASC Topic 718, the Company recognizes an expense for the fair value of outstanding stock options and grants as they vest, whether held by employees or others. During the three months ended May 31, 2026, the 5,000 shares available to Mr. Matson under his employment agreement vested, but were not exercised during the 30 day period following the end of the quarter.    No vesting of stock options or grants occurred during three months ended May 31, 2025. Please see Note 10. Stock Options and Grants for additional information.  

 

 

3.

REVENUE RECOGNITION

 

Sales returns and allowances accrual activity is shown below for May 31, 2026, and February 28, 2026.

 

    
  

May 31, 2026

  

February 28, 2026

 

Beginning Balance

 $265,000  $310,000 

Accrued Allowances and Adjustments

  (38,000)  (45,000)

Ending Balance

 $227,000  $265,000 

 

 

As mentioned in Note 2 above, one of our distributor agreements has a termination clause that would allow for a full credit for all inventory upon 60 days’ notice of terminating the agreement. As of May 31, 2026, and February 28, 2026, the inventory balance at that distributor was believed to be $874,000 and $1,014,000, respectively. Based upon sales levels to and by the distributor during the period, inventory levels at the distributors, current and projected market conditions, and historical experience under the programs, we believe it is highly unlikely that the distributor would exercise termination. Should termination occur, we believe the products could be sold to other distributors or held in inventory for future sale.

 

The Company warrants that its products, when delivered, will be free from defects in material workmanship under normal use and service. The obligations are limited to replacing, repairing, or reimbursing for, at the option of the Company, any products that are returned within one year after the date of shipment. The Company does not reserve for potential warranty costs based on historical experience and the nature of its cost tracking system.

 

 

4.

INVENTORIES

 

As of May 31, 2026, inventories consist of the following:

 

  

Gross

  

Reserve

  

Net

 

Raw Materials

 $3,456,000  $(551,000) $2,905,000 

Work-In-Process

  5,416,000   (4,021,000)  1,395,000 

Finished Goods

  753,000   (486,000)  267,000 

Totals

 $9,625,000  $(5,058,000) $4,567,000 

 

 

10

 

As of February 28, 2026, inventories consist of the following:

 

  

Gross

  

Reserve

  

Net

 

Raw Materials

 $3,275,000  $(534,000) $2,741,000 

Work-In-Process

  5,245,000   (4,017,000)  1,228,000 

Finished Goods

  646,000   (483,000)  163,000 

Totals

 $9,166,000  $(5,034,000) $4,132,000 

 

 

Wafer bank inventory (completed wafers that are available to be consumed in the Company’s products), net of reserves, totaled $61,000 as of May 31, 2026 and $61,000 as of February 28, 2026. As of May 31, 2026, 100% of the wafer bank inventory consisted of wafers manufactured between calendar year 2018 and 2022. We do not expect all of our wafer inventory to be consumed within twelve months; however, since it is not possible to know which wafers will or will not be used, we classify all our inventory as current.

 

 

5.

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

 

As of May 31, 2026, and February 28, 2026, accrued expenses and other current liabilities consist of the following:

 

  

May 31, 2026

  

February 28, 2026

 

Payroll and related employee benefits

 $843,000  $728,000 

Legal fees

  8,000   28,000 

Property, sales, and franchise taxes

  78,000   46,000 

Return allowance

  227,000   265,000 

Totals

 $1,156,000  $1,067,000 

 

 

 

6.

DISAGGREGATION OF REVENUE AND MAJOR CUSTOMERS

 

Revenues from domestic and export sales are attributed to a global geographic region according to the location of the customer’s primary manufacturing or operating facilities. Revenues from domestic and export sales to unaffiliated customers for the three months ended May 31, 2026, and May 31, 2025, respectively are as follows:

 

Geographic Region

 

May 31, 2026

  

May 31, 2025

 

Europe and Australia

 $249,000  $33,000 

Canada and Latin America

  -   - 

Far East and Middle East

  -   11,000 

United States

  5,187,000   2,656,000 

Totals

 $5,436,000  $2,700,000 

 

For the three months ended May 31, 2026 and May 31, 2025, approximately 64% and 53%, respectively, of the Company’s sales have been attributable to contracts with customers whose products are sold to the United States government. The remaining 36% and 47%, respectively of sales are for non-military, scientific and industrial applications, or to distributors where we do not have end user information.

 

11

 

Customers who contributed ten percent or more of revenues for the three months ended May 31, 2026, and May 31, 2025, respectively are as follows:

 

Customer

 

May 31, 2026

  

Customer

 

May 31, 2025

 

1. RTX (Raytheon)

  31% 

1. RTX (Raytheon)

  34%

2. ConMed Linvatec

  27% 

2. ConMed Linvatec

  26%

3. L3Harris

  19% 

3. MOOG

  11%

Totals

  77% 

Totals

  71%

 

 

7.

MAJOR SUPPLIERS

 

For the three months ended May 31, 2026, the Company utilized four suppliers who in total provided 66% of the production materials. Individually, these suppliers accounted for 30%, 16%, 10%  and 10% of the Company's production materials.  No other supplier accounted for 10% or more of purchases of production materials.  

 

For the three months ended May 31, 2025, the Company utilized two suppliers who in total provided 82% of the production materials. Individually, these suppliers accounted for 57% and 25% of the Company's production materials.  No other supplier accounted for 10% or more of purchases of production materials.  

 

 

8.

COMMITMENTS AND CONTINGENCIES

 

Contingencies:

We may from time to time become a party to various legal proceedings arising in the ordinary course of business. As of May 31, 2026, we had no known material current, pending, or threatened litigation.

 

 

12

 

 

 

9.

NOTES PAYABLE

 

On April 16, 2021, the Company closed on the acquisition of a facility and real estate located in West Palm Beach, Florida for a purchase price of $4,200,000 pursuant to the Commercial Contract entered into on March 1, 2021. In connection with the acquisition, the Company obtained mortgage financing from Bank of America, N.A. (the “Bank”) in the amount of $2,940,000 to fund that portion of the total purchase price, and entered into the Master Credit Agreement, a Note, a Mortgage, Assignment of Rents, Security Agreement and Fixture Filing and Financial Covenant Agreement (the “FCA”). The loan accrues interest at a fixed rate of 3.8% per year and matures on April 15, 2031. Beginning on May 15, 2021, the Company began making monthly installments of $17,593 consisting of principal and interest. The payment and performance of the loan is secured by a security interest in the property acquired. As of May 31, 2026, the principal balance due on the note was $2,391,000.

 

On May 21, 2024, Micro Engineering, Inc., a wholly owned subsidiary of Solitron purchased the property and facilities occupied by the Company, located at 401 Roger Williams Road, Apopka, Florida (the “Micro Property”), for a purchase price of $1,750,000. Micro Engineering, Inc. previously occupied the Micro Property under a commercial lease agreement dated September 1, 2023, which provided the Company with an option to purchase the Micro Property for $1,750,000 at any time before the six-month anniversary of the lease agreement. In addition, on May 21, 2024, the Company entered into a Loan Agreement with Bank of America, N.A. (“the Bank”) with respect to the Company’s acquisition of the Micro Property. The Loan Agreement is (1) evidenced by a Promissory Note issued by the Company in favor of the Bank in the principal amount of $1,400,000 and (2) secured by the Micro Property and certain related assets and rights pursuant to a Mortgage, Assignment of Rents, Security Agreement and Fixture Filing between the Bank and Micro Engineering. The Micro Property is subject to the Mortgage, Assignment of Rents, Security Agreement and Fixture Filing. Furthermore, Micro Engineering guaranteed the Company’s obligations under the Promissory Note pursuant to a Continuing and Unconditional Guaranty.

 

13

 

Pursuant to the loan documentation, the Bank has advanced $1,400,000 to the Company for the purchase of the Micro Property. The Company agreed to pay installments of principal and interest in the amount of $10,444 on the first day of each month, commencing on July 1, 2024, and continuing on the same day of each calendar month thereafter, through May 1, 2034. The Company agreed to pay all remaining outstanding principal, together with all then accrued and unpaid interest, on May 31, 2034. The outstanding principal amount of the loan may be prepaid at any time with accrued interest and the interest payment that would have accrued through the term of the loan with respect to the prepayment amount. The loan is scheduled to mature on May 31, 2034. Interest on the outstanding principal amount of the loan is payable monthly at the annual rate equal to 6.39% per annum.  As of May 31, 2026, the principal balance due on the note was $1,332,000.

 

As of May 31, 2026 and  February 28, 2026 principal payments on the notes payable are as follows:

 

Total Principal Payments

        
         
  

May 31, 2026

  

February 28, 2026

 

2027

 $118,000  $160,000 

2028

  167,000   167,000 

2029

  174,000   174,000 

2030

  183,000   183,000 

2031

  191,000   191,000 

Thereafter

  2,890,000   2,890,000 

Total principal payments

 $3,723,000  $3,765,000 

 

 

 

10.

STOCK OPTIONS AND GRANTS

 

Repurchase Program

 

On October 14, 2024, the Board of Directors authorized an increase in the Company's stock repurchase program of up to $2,000,000 of its outstanding common stock. Purchases under the program may be made through the open market or privately negotiated transactions as determined by the Company’s management, and in accordance with the requirements of the Securities and Exchange Commission. The timing and actual number of shares repurchased will depend on variety of factors including price, corporate and regulatory requirements and other conditions.

 

The company did not repurchase any shares under the stock repurchase program during the three months ended May 31, 2026 and 2025.

 

Stock Options and Grants

 

Under the terms of the updated employment agreement with Mr. Matson effective as of August 13, 2025, Mr. Matson was given the right to purchase up to 50,000 shares of Company common stock for $14.50 per share within 90 days after the effective date of the new employment agreement.  In addition, during the initial term of the updated employment agreement, which has a three-year term through August 2028, Mr. Matson has the ability to purchase 5,000 shares within 30 days after the end of each quarter, as long as he fulfills the service requirement to work through the last day of each quarter, based on the weighted average share price during the quarter. These shares are issued from treasury shares and are not through the Company's 2019 Stock Incentive Plan. Mr. Matson did not elect to purchase the 5,000 shares available under his employment agreement for the quarter ending May 31, 2026.  

.  

 

 

 

 

14

 
 

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Solitron Devices, Inc., a Delaware corporation (the “Company” or “Solitron”), designs, develops, manufactures and markets solid-state semiconductor components and related devices primarily for the military and aerospace markets. The Company manufactures a large variety of bipolar and metal oxide semiconductor (“MOS”) power transistors, power and control hybrids, junction and power MOS field effect transistors and other related products. Most of the Company’s products are custom made pursuant to contracts with customers whose end products are sold to the United States government. Other products, such as Joint Army/Navy transistors, diodes and Standard Military Drawings voltage regulators, are sold as standard or catalog items.

 

The following discussion and analysis of factors which have affected the Company's financial position and operating results during the periods included in the accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Audited Consolidated Financial Statements and the related Notes to Financial Statements and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Annual Report on Form 10-K for the year ended February 28, 2026 and the Unaudited Condensed Consolidated Financial Statements and the related Notes to Unaudited Financial Statements included in Item 1 of this Quarterly Report on Form 10-Q.

 

Critical Accounting Estimates:

 

The discussion and analysis of our financial condition and results of operations are based upon the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q which are prepared in accordance with GAAP. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by management’s application of accounting policies. See Note 2 in the financial statements for the Company’s significant accounting policies. Of the Company’s accounting policies, the following are considered to be critical – Revenue Recognition and Inventories. A discussion of these critical accounting policies are included in Note 2 of the “Notes To Financial Statements” in Item 8 of our Annual Report on Form 10-K for the fiscal year ended February 28, 2026.

 

See Note 2, “Summary of Significant Accounting Policies”, to the accompanying notes to the financial statements included in this Quarterly Report on 10-Q.

 

Results of Operations-Three Months Ended May 31, 2026, Compared to Three Months Ended May 31, 2025:

 

Net Sales. Net sales for the three months ended May 31, 2026, increased 101% to $5,436,000 as compared to $2,700,000 for the three months ended May 31, 2025. The increase in net sales was largely due to increased backlog in fiscal year 2026 as compared to fiscal year 2025 and the associated delivery dates of those orders.

 

Net bookings for the three months ended May 31, 2026, decreased 48% to $1,454,000 versus $2,797,000 during the three months ended May 31, 2025 primarily due to the variable timing on the receipt of orders. Backlog as of May 31, 2026, increased 28% to $23,341,000 as compared to a backlog of $18,256,000 as of May 31, 2025. The large order MEI received, which increased the contingent consideration liability, was received after the end of the quarter and is not included in the backlog numbers shown above.

 

Cost of Sales. Cost of sales for the three months ended May 31, 2026, increased to $2,971,000 from $2,310,000 for the three months ended May 31, 2025. However, expressed as a percentage of net sales, cost of sales decreased to 55% for the three months ended May 31, 2026, compared to 86% for the three months ended May 31, 2025.

 

Gross Profit. Gross profit for the three months ended May 31, 2026, increased to $2,465,000 from $390,000 for the three months ended May 31, 2025. Expressed as a percentage of net sales, gross profit increased to 45% for the three months ended May 31, 2026, compared to 14% for the three months ended May 31, 2025. This increase is due to the overall higher revenue during the quarter.

 

For the three months ended May 31, 2026, we shipped 23,968 units as compared to 15,035 units shipped during the same period of the prior year. It should be noted that since we manufacture a wide variety of products with an average sales price ranging from a few dollars to several hundred dollars, such periodic variations in our volume of units shipped should not be regarded as a reliable indicator of our performance.

 

Selling, General & Administrative Expenses. Selling, general, and administrative expenses increased to $930,000 for the three months ended May 31, 2026 from $768,000 for the three months ended May 31, 2025.  Expressed as a percentage of net sales, selling, general and administrative expenses during the three months ended May 31, 2026, was 17% as compared to 28% for the three months ended May 31, 2025. This increase is due to higher corporate salaries and related expenses.  

 

Operating Income (Loss). The operating income for the three months ended May 31, 2026, was $1,535,000 as compared to operating loss of ($378,000) for the three months ended May 31, 2025. This increase is income is due to the overall higher revenue during the quarter.

 

Other Income (Loss). Interest income increased to $82,000 for the three months ended May 31, 2026, as compared to $0 for the three months ended May 31, 2025. This increase was due to interest received on the Company's long-term investment in addition to interest received on a tax refund.  Interest expense decreased to ($62,000) for the three months ended May 31, 2026, as compared to ($74,000) for the three months ended May 31, 2025.  Dividend income decreased to $25,000 for the three months ended May 31, 2026, as compared to $41,000 for the three months ended May 31, 2025. Realized gains on investments for the three months ended May 31, 2026, decreased to $0, due to the Company liquidating its marketable securities, as compared to $81,000 for the three months ended May 31, 2025. Unrealized gains (losses) on investments for the three months ended May 31, 2026, were ($2,000) due to market price changes in the company’s common stock investments as compared to  ($127,000) for the three months ended May 31, 2025. Contingent consideration expense was ($331,000) for the three months ended May 31, 2026, as compared to $0 for the three months ended May 31, 2025. This adjustment to the contingent consideration was due to the increase in MEI's backlog for a large order received after the end of the quarter, which increased the earn out payment on the MEI acquisition. Scrap income was $100,000 for the three months ended May 31, 2026, as compared to $0 for the three months ended May 31, 2025.

 

15

 

Income (Taxes) Benefit. Income taxes for the three months ended May 31, 2026, increased to ($357,000) as compared to $121,000 for the three months ended May 31, 2025.  This change in income tax is due to the company's higher income in the current quarter ended May 31, 2026 compared to the three months ended May 31, 2025.

 

Net Income (Loss). Net income for the three months ended May 31, 2026, was $990,000 as compared to net loss of ($336,000) for the three months ended May 31, 2025. 

 

Liquidity and Capital Resources:

 

Operating Activities:

Net cash provided by operating activities was $2,171,000 for the three months ended May 31, 2026, primarily reflecting net income of $990,000, depreciation of $154,000, amortization of intangibles of $52,000, a decrease in net deferred taxes of $357,000, a decrease in accounts receivable of $366,000, an increase in contingent consideration of $331,000 and a decrease in other non-current assets of $284,000, partially offset by an increase in inventories of $435,000 and increase in prepaid expenses and other current assets of $181,000.

 

Net cash provided by operating activities was $391,000 for the three months ended May 31, 2025, primarily reflecting a net loss of $336,000, a decrease in accounts receivable of $379,000, an increase in accounts payable of $293,000, depreciation of $141,000, an increase in other non-current assets of $127,000 and an increase in net deferred taxes of $121,000, partially offset by an increase in inventories of $151,000.

 

Investing Activities:

Net cash used in investing activities was ($114,000) for the three months ended May 31, 2026, principally reflecting $114,000 in purchases of property and equipment.

 

Net cash used in investing activities was ($1,883,000) for the three months ended May 31, 2025, principally reflecting $1,650,000 in purchases of a long-term investment, and $409,000 of cash paid for acquisition, contingent consideration, partially offset by proceeds from the sale of marketable securities of $296,000.

 

Financing Activities:

Net cash provided by financing activities was $65,000 for the three months ended May 31, 2026, principally reflecting $107,000 in sales of the Company's stock, partially offset by $42,000 in principal payments on the mortgage loans.

 

Net cash used in financing activities was ($37,000) for the three months ended May 31, 2025, principally reflecting $37,000 in principal payments on the mortgage loans.

 

We expect our sole sources of liquidity over the next twelve months to be cash from operations and cash and cash equivalents, if necessary. We anticipate that our capital expenditures required to sustain operations will be approximately $250,000 during the next twelve months and that our cash from operations and cash and cash equivalents, if necessary, will be sufficient to fund these needs for the next twelve months. Available cash and cash equivalents as of June 30, 2026 was approximately $6.1 million.

 

At May 31, 2026 and February 28, 2026, we had cash and cash equivalents of approximately $6,036,000 and $3,914,000, respectively. The increase for the three months ended May 31, 2026, was primarily due to the cash provided by increased sales over the last few quarters..

 

At May 31, 2026 and February 28, 2026, we had investments in securities of approximately $0 and $2,000, respectively.  This is due to the Company selling its marketable securities.

 

At May 31, 2026 and February 28, 2026, we had working capital of $10,812,000 and $9,025,000, respectively. The increase for the three months ended May 31, 2026 was due primarily to the cash provided by increased sales over the last few quarters.

 

Based on various factors, including the Company’s desire to fully utilize its current net operating loss carryforwards, the Company may seek out acquisitions, additional product lines, and/or invest a portion of its cash into higher yielding debt instruments. 

 

The Company will also continue to consider additional share repurchases under the Company's stock repurchase program subject to market conditions, corporate liquidity requirements and priorities and other factors as may be considered in the Company’s sole discretion.

 

Off-Balance Sheet Arrangements:

The Company has not engaged in any off-balance sheet arrangements.

 

16

 

FORWARD-LOOKING STATEMENTS

Some of the statements in this Quarterly Report on Form 10-Q are “forward-looking statements”. These forward-looking statements include statements regarding our business, financial condition, results of operations, strategies or prospects and potential strategic transactions. You can identify forward-looking statements by the fact that these statements do not relate strictly to historical or current matters. Rather, forward-looking statements relate to anticipated or expected events, activities, trends or results. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These factors include those described under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended February 28, 2026, including those identified below. We do not undertake any obligation to update forward-looking statements, except as required by law.

 

Some of the factors that may impact our business, financial condition, results of operations, strategies or prospects include:

 

 

Loss of, or reduction of business from, significant customers could hurt our business by reducing our revenues, profitability and cash flow.

 

Our complex manufacturing processes may lower yields and reduce our revenues.

 

Our business could be materially and adversely affected if we are unable to obtain qualified supplies of raw materials, parts and finished components on a timely basis and at a cost-effective price.

 

We are dependent on government contracts, which are subject to termination, price renegotiations and regulatory compliance, which can increase the cost of doing business and negatively impact our revenues.

 

Changes in government policy or economic conditions or technology or reduction in government spending to which our business relates could negatively impact our results.

 

Our business is highly competitive and increased competition could reduce gross profit margins and the value of an investment in our Company.

 

Changes in Defense related programs and priorities could reduce the revenues and profitability of our business.

 

Our operating results may decrease due to the decline of profitability in the semiconductor industry.

 

Uncertainty of current economic conditions, domestically and globally, could continue to affect demand for our products and negatively impact our business.

 

Our inability to introduce new products could result in decreased revenues and loss of market share to competitors; new technologies could also reduce the demand for our products.

 

Provisions in our charter documents could make it more difficult to acquire our Company and may reduce the market price of our stock.

 

Failure to protect our proprietary technologies or maintain the right to use certain technologies may negatively affect our ability to compete.

 

We cannot guarantee that we will have sufficient capital resources to make necessary investments in manufacturing technology and equipment.

 

While we attempt to monitor the credit worthiness of our customers, we may be at risk due to the adverse financial condition of one or more customers.

 

Our international operations expose us to material risks, including risks under U.S. export laws.

 

Security breaches and other disruptions could compromise the integrity of our information and expose us to liability, which would cause our business and reputation to suffer.

 

Our failure to fully remediate and test the controls put in place related to the material weakness in our internal control over financial reporting or our identification of any other material weaknesses in the future may adversely affect the accuracy and timing of our financial reporting.

 

17

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

This item is not applicable as we are currently considered a smaller reporting company.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Our Evaluation of Disclosure Controls and Procedures

 

The Company carried out an evaluation, under the supervision and with the participation of its management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e), and 15d-15(e) as of the end of the period covered by this Quarterly Report.

 

Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our new disclosure controls and procedures were appropriately designed. However, based on the timing of when the controls were implemented, there was not sufficient evidence to test whether these controls were operating effectively as of May 31, 2026 to remediate the material weakness described in the Company’s Annual Report on Form 10-K for the year ended February 28, 2026 under “Management’s Report on Internal Control over Financial Reporting”. Because of its inherent limitations, internal control over financial reporting may not prevent or detect all misstatements or fraud. Any control system, no matter how well designed and operated, is based upon certain assumptions and can provide only reasonable, not absolute, assurance that its objectives will be met. However, giving full consideration to the material weakness and the remediation plan, the Company’s management has concluded that the Company’s financial statements included in this Quarterly Report fairly present, in all material respects, the Company’s financial condition and results of operations as of and for the three months ended May 31, 2026.

 

Changes in Internal Control over Financial Reporting.

 

There were no changes in the Company’s internal control over financial reporting during the quarter ended May 31, 2026, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

18

 

 

PART II OTHER INFORMATION

 

 

ITEM 1. LEGAL PROCEEDINGS

 

We may from time to time become a party to various legal proceedings arising in the ordinary course of business. As of May 31, 2026, we had no known material current, pending, or threatened litigation.

 

ITEM 1A. RISK FACTORS

 

In addition to the information set forth in this Form 10-Q, you should carefully consider the risk factors discussed in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended February 28, 2026, which could materially affect our business, financial condition or future results.

 

 

ITEM 6. EXHIBITS

 

       

 

 

Filed or

       

Incorporated by

 

Furnished

        Reference  

Herewith

Exhibit #

 

Exhibit Description

 

Form

 

Date

 

Number

   

3.1

 

Certificate of Incorporation

 

10-K

 

2/28/1993

 

-

   

3.2

 

Amended and Restated By-laws of Solitron Devices, Inc.

 

8-K

 

7/27/2016

 

3.1

   

31.1

 

Certification of Chief Executive Officer and Chief Financial Officer (302)

             

Filed

32.1

 

Certification of Chief Executive Officer and Chief Financial Officer (906)

             

Furnished

101.INS

 

Inline XBRL Instance Document.

             

Filed

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document.

             

Filed

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

             

Filed

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document.

             

Filed

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document.

             

Filed

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

             

Filed

104

 

Cover Page Interactive Data File (Embedded as Inline XBRL document and contained in Exhibit 101).

               

 

19

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

SOLITRON DEVICES, INC.

 

 

 

 

Date: July 13, 2026    

 

/s/ Tim Eriksen

 

 

Tim Eriksen

 

 

Chief Executive Officer

 

     
     
Date: July 13, 2026    
  /s/ Carolyn Campbell  
  Carolyn Campbell  
  Chief Financial Officer  

 

20

ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EXHIBIT 31.1

EXHIBIT 32.1

XBRL TAXONOMY EXTENSION SCHEMA

XBRL TAXONOMY EXTENSION CALCULATION LINKBASE

XBRL TAXONOMY EXTENSION DEFINITION LINKBASE

XBRL TAXONOMY EXTENSION LABEL LINKBASE

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: R6.htm

IDEA: R7.htm

IDEA: R8.htm

IDEA: R9.htm

IDEA: R10.htm

IDEA: R11.htm

IDEA: R12.htm

IDEA: R13.htm

IDEA: R14.htm

IDEA: R15.htm

IDEA: R16.htm

IDEA: R17.htm

IDEA: R18.htm

IDEA: R19.htm

IDEA: R20.htm

IDEA: R21.htm

IDEA: R22.htm

IDEA: R23.htm

IDEA: R24.htm

IDEA: R25.htm

IDEA: R26.htm

IDEA: R27.htm

IDEA: R28.htm

IDEA: R29.htm

IDEA: R30.htm

IDEA: R31.htm

IDEA: R32.htm

IDEA: R33.htm

IDEA: R34.htm

IDEA: R35.htm

IDEA: R36.htm

IDEA: R37.htm

IDEA: R38.htm

IDEA: R39.htm

IDEA: R40.htm

IDEA: R41.htm

IDEA: R42.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: sodi20260531_10q_htm.xml